Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-03-11A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours
-
CLINICAL_TRIALS study record update · 2016-03-09An Open-label, Non-randomized, Multicenter Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY 1238097 in Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2016-02-29ClinicalTrials.gov study NCT00005494
-
CLINICAL_TRIALS study record update · 2016-02-12A Phase Ib Dose Escalation Study of Afatinib in Combination With Cetuximab in Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2016-02-10A Phase 1/1B Dose-Escalation Study to Determine the Safety and Tolerability of SCH 717454 Administered in Combination With Chemotherapy in Pediatric Subjects With Advanced Solid Tumors (Protocol No. 05883)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-02-02Phase II Trial of Subcutaneous Methylnaltrexone in the Treatment of Severe Opioid-induced Constipation in Cancer Patients
-
CLINICAL_TRIALS study record update · 2016-01-21Exploring the Desirability, Feasibility and Practicalities of Using Information and Communication Technology (ICT) to Improve Cancer Pain Management in the Community
-
CLINICAL_TRIALS study record update · 2016-01-18A Phase 1 Study Evaluating A Second Generation Antisense Oligonucleotide (OGX 427) That Inhibits Heat Shock Protein 27 (Hsp27
-
CLINICAL_TRIALS study record update · 2015-12-28Clinical Trials of CT-guided Percutaneous Irreversible Electroporation（IRE）in the Treatment of Patients With Locally Advanced Tumors：The Safety and Efficacy Assessment
-
CLINICAL_TRIALS study record update · 2015-12-28Phase 2 Study of Autologous Tumor Lysate-pulsed DC-CIK Cell in Colorectal Cancer After Surgery
-
CLINICAL_TRIALS study record update · 2015-12-22A Dose-Escalation Study to Evaluate the Safety and Tolerability of SCH 717454 in Combination With Different Treatment Regimens in Subjects With Advanced Solid Tumors (Phase 1B/2; Protocol No. P04722)
-
CLINICAL_TRIALS study record update · 2015-12-15Randomised Controlled Trial of Qigong Training Programme to Alleviate Arm Oedema, ¬Reduce Shoulder Impairment, Improve Body Balance and Quality of Life in Community-dwelling Breast Cancer Survivors
-
CLINICAL_TRIALS study record update · 2015-12-15Efficacy and Safety of Radiofrequency Ablation of Malignant Pulmonary Nodules
-
CLINICAL_TRIALS study record update · 2015-12-14Investigation of Mass Balance and Major Metabolites After Administration of 28 mg Radiolabeled ZK 219477 in Patients With Solid Tumor in an Open-label, Non Randomized Design
-
CLINICAL_TRIALS study record update · 2015-12-09An Open Label Phase I Dose Finding Study of BI 853520 Administered Orally in a Continuous Dosing Schedule in Patients With Various Advanced or Metastatic Non-hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2015-12-04A Pivotal Bioequivalence Study of DOXIL/CAELYX Manufactured at a New Site in Subjects With Advanced or Refractory Solid Malignancies Including Subjects With Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2015-10-28A Phase I Clinical, Pharmacokinetic, And Pharmacodynamic Evaluation Of 2 Schedules Of Oral PD 0332991, A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2015-10-28A Phase I Study of Cetuximab in Combination With Erlotinib in Patients With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2015-10-27A Phase 1, Multi-center, Non-randomized, Open Label, Dose Escalation Design Study of Sorafenib (BAY43-9006) in Combination With Eribulin in Subjects With Advanced, Metastatic or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-09-04The Response and Outcomes of Pegylated Interferon Plus Ribavirin Combination Therapy for Chronic Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2015-09-02An Open-label, Dose-escalation Study With Extension to Evaluate Safety, Pharmacokinetics and Anti-tumor Activity of RO4987655, a MEK Inhibitor, Administered Orally as Monotherapy in Patients With Advanced Tumors
-
CLINICAL_TRIALS study record update · 2015-08-28A Phase I Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Asian Patient With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-08-24A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients
-
CLINICAL_TRIALS study record update · 2015-08-21A Randomised Double Blind Placebo Controlled Phase II Study of Fulvestrant With or Without the Addition of Vandetanib as Treatment for Patients With Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy
-
CLINICAL_TRIALS study record update · 2015-08-18ClinicalTrials.gov study NCT01901172